Clincosm LogoSign in Get a demo

nonalcoholic steatohepatitis

Showing 26 - 50 of 122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonalcoholic Steatohepatitis Trial in Worldwide (Semaglutide (SEMA), Cilofexor (CILO)/Firsocostat (FIR), PTM SEMA)

Recruiting
  • Nonalcoholic Steatohepatitis
  • Semaglutide (SEMA)
  • +3 more
  • Birmingham, Alabama
  • +149 more
Jul 28, 2022

Metabolic Pathology of Pediatric NAFLD

Recruiting
  • Nonalcoholic Fatty Liver
  • +2 more
  • Cardiometabolic testing
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Jun 28, 2022

Hepatic Cirrhosis, Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD) Trial in Japan, United States (BMS-986036, Placebo)

Completed
  • Hepatic Cirrhosis
  • +3 more
  • Madison, Alabama
  • +90 more
May 9, 2022

Nonalcoholic Steatohepatitis Trial (Saroglitazar Magnesium 4 mg, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis
  • Saroglitazar Magnesium 4 mg
  • Placebo
  • (no location specified)
Apr 23, 2022

Nonalcoholic Steatohepatitis Trial in Cairo (Heptex, Rice bran)

Completed
  • Nonalcoholic Steatohepatitis
  • Cairo, Egypt
  • +1 more
Apr 18, 2022

NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

Not yet recruiting
  • Nonalcoholic Fatty Liver Disease
  • +3 more
    • (no location specified)
    Apr 18, 2022

    Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Trial in San Diego, Boston (device, diagnostic test, other)

    Completed
    • Nonalcoholic Steatohepatitis
    • Nonalcoholic Fatty Liver
    • Ultrasound based shear wave speed and fat quantification methods
    • +3 more
    • San Diego, California
    • +1 more
    Apr 11, 2022

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Seoul (Intermittent calorie restriction, Standard of care)

    Recruiting
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Intermittent calorie restriction
    • Standard of care
    • Seoul, Yangcheon-gu, Korea, Republic of
      Ewha Womans University College of Medicine
    Mar 24, 2022

    Compensated Cirrhosis, Nonalcoholic Steatohepatitis Trial in Worldwide (aldafermin, Placebo)

    Active, not recruiting
    • Compensated Cirrhosis
    • Nonalcoholic Steatohepatitis
    • aldafermin
    • Placebo
    • Glendale, Arizona
    • +79 more
    Mar 4, 2022

    Nonalcoholic Steatohepatitis Trial in Washington (Proglumide)

    Active, not recruiting
    • Nonalcoholic Steatohepatitis
    • Washington, District of Columbia
    • +1 more
    Mar 14, 2022

    Nonalcoholic Steatohepatitis Trial in Worldwide (Placebo, Cenicriviroc)

    Terminated
    Has Results
    • Nonalcoholic Steatohepatitis
    • Birmingham, Alabama
    • +345 more
    Feb 11, 2022

    Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Hungary, Poland, Spain (Placebo, FM101 150 mg BID, FM101

    Recruiting
    • Nonalcoholic Fatty Liver Disease
    • Nonalcoholic Steatohepatitis
    • Placebo
    • +2 more
    • Budapest, Hungary
    • +11 more
    Mar 4, 2022

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Boston (Aspirin 81 mg, Placebo oral tablet)

    Recruiting
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Aspirin 81 mg
    • Placebo oral tablet
    • Boston, Massachusetts
      Massachusetts General Hospital
    Feb 23, 2022

    Innovative Liver Elasticity, Attenuation, and Dispersion

    Recruiting
    • Nonalcoholic Steatohepatitis
    • +2 more
    • Ultrasound application
    • Los Angeles, California
    • +17 more
    Feb 6, 2022

    Nonalcoholic Steatohepatitis, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease Trial in Worldwide (Cenicriviroc)

    Terminated
    Has Results
    • Nonalcoholic Steatohepatitis
    • +2 more
    • Dothan, Alabama
    • +70 more
    Jan 4, 2022

    Fatty Liver, Nonalcoholic, NAFLD, Nonalcoholic Fatty Liver Disease Trial in United States (HTD1801, Placebo)

    Completed
    Has Results
    • Fatty Liver, Nonalcoholic
    • +5 more
    • Chandler, Arizona
    • +16 more
    Nov 30, 2021

    Diabetes, Type 2, PreDiabetes, Insulin Resistance Trial in Stanford (Dietary Intervention)

    Recruiting
    • Diabetes Mellitus, Type 2
    • +6 more
    • Dietary Intervention
    • Stanford, California
      Stanford University
    Dec 7, 2021

    Obesity, Weight Loss, Body Weight Trial in Saint Louis (Embospheres Microspheres)

    Not yet recruiting
    • Obesity
    • +5 more
    • Embospheres Microspheres
    • Saint Louis, Missouri
      Saint Louis University
    Nov 15, 2021

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Elobixibat 10mg + cholestyramine powder 9g

    Completed
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Elobixibat 10mg + cholestyramine powder 9g (cholestyramine 4g)
    • +3 more
    • Yokohama, Kanagawa, Japan
      Yokohama City University
    Nov 15, 2021

    Nonalcoholic Steatohepatitis, Type 2 Diabetes Trial (TEV-45478, Placebo)

    Withdrawn
    • Nonalcoholic Steatohepatitis
    • Type 2 Diabetes Mellitus
    • (no location specified)
    Nov 5, 2021

    Obesity, Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease Trial in Cincinnati (Comprehensive Lifestyle

    Completed
    • Obesity
    • +2 more
    • Comprehensive Lifestyle Intervention
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Nov 1, 2021

    Type 2 Diabetes, Obesity, Nonalcoholic Steatohepatitis Trial in Melbourne (Cohort A, Placebo A, Cohort B)

    Completed
    • Type 2 Diabetes Mellitus
    • +2 more
    • Cohort A
    • +3 more
    • Melbourne, Victoria, Australia
      Nucleus Network Pty Ltd
    Oct 20, 2021

    Nonalcoholic Steatohepatitis Trial in Vienna (norUrsodeoxycholic acid)

    Recruiting
    • Nonalcoholic Steatohepatitis
    • norUrsodeoxycholic acid
    • Vienna, Austria
      Medical University of Vienna, Department of Internal Medicine II
    Oct 20, 2021

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Obesity Trial in Columbia (Phase II: Lifestyle treatment, Phase II:

    Recruiting
    • Nonalcoholic Fatty Liver
    • +2 more
    • Phase II: Lifestyle treatment
    • +2 more
    • Columbia, Missouri
      University of Missouri
    Oct 22, 2021

    Nonalcoholic Steatohepatitis, Type 2 Diabetes Trial in Toronto (routine screening, physician-driven screening)

    Recruiting
    • Nonalcoholic Steatohepatitis
    • Type 2 Diabetes
    • routine screening
    • physician-driven screening
    • Toronto, Ontario, Canada
      LMC Diabetes & Endocrinology Ltd.
    Aug 25, 2021